Sleep Disorder Connect
  • Saved

1yr
Clinical considerations in the treatment of idiopathic hypersomnia - PubMed

Clinical considerations in the treatment of idiopathic hypersomnia - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/38796978/

Idiopathic hypersomnia typically is a chronic and potentially debilitating neurologic sleep disorder, and is characterized by excessive daytime sleepiness. In addition to excessive daytime sleepiness, idiopathic hypersomnia symptoms can include...

Idiopathic hypersomnia is a chronic sleep disorder marked by excessive daytime sleepiness and cognitive dysfunction. Treatment includes low-sodium oxybate and off-label options, emphasizing personalized approaches and nonpharmacologic therapies.

  • Saved

1yr
Orthodontic appliances for the treatment of pediatric obstructive sleep apnea: A systematic review and network meta-analysis - PubMed

Orthodontic appliances for the treatment of pediatric obstructive sleep apnea: A systematic review and network meta-analysis - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/37820534/

This systematic review and network meta-analysis aims to preliminarily investigate the efficacy of different orthodontic appliances for the treatment of pediatric obstructive sleep apnea (OSA). Electronic databases were systematically searched....

This review found that mandibular advancement appliances (MAA), RME combined with adenotonsillectomy (AT), and myofunctional therapy (MFT) reduced apnea-hypopnea index (AHI) in pediatric obstructive sleep apnea, while RME alone was ineffective.

  • Saved

1yr
The Function of Sleep and the Treatment of Primary Insomnia - PubMed

The Function of Sleep and the Treatment of Primary Insomnia - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/37942822/

Behavioral therapy is underused despite clear evidence of efficacy, while drugs are given too often. Better patient education and the use of digital applications might help increase the utilization of...

Behavioral therapy is underused for insomnia despite proven long-term effectiveness, while drugs are overprescribed. Digital tools and patient education could improve behavioral therapy adoption and reduce reliance on hypnotic medications.

  • Saved

1yr
Boston Chest 2024: Key Research Highlights in Sarcoidosis, Asthma, COPD, and Lung Cancer

In this video from the Boston Chest 2024 Conference, Dr. Jack D. Buckley, a pulmonary and critical care physician and professor at Western Michigan University, and Dr. Arianne Baldamero, a staff physician at the Minneapolis VA and assistant professor at the University of Minnesota, present cutting-edge research. They explore advancements in sarcoidosis treatment, novel biomarkers for asthma and COPD management, and innovative lung cancer therapies. Additionally, they highlight healthcare disparities in access to care and technology between urban and rural populations. These findings offer clinicians valuable insights to enhance treatment strategies for a variety of pulmonary disorders.

  • 1yr
    the first line therapy here based on presentation and lung function would be a LAMA/LABA, in addition to the usual care/feeding of the patient (diet, exercise, pulmonary rehab, smoking cessation, Show More
  • Saved

1yr
Clinical Practice Guidelines for Cannabis and Cannabinoid-Based Medicines in the Management of Chronic Pain and Co-Occurring Conditions - PubMed

Clinical Practice Guidelines for Cannabis and Cannabinoid-Based Medicines in the Management of Chronic Pain and Co-Occurring Conditions - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/36971587/

Background: One in five individuals live with chronic pain globally, which often co-occurs with sleep problems, anxiety, depression, and substance use disorders. Although these conditions are commonly managed with cannabinoid-based...

This study presents clinical guidelines for cannabinoid-based medicine (CBM) in managing chronic pain and co-occurring conditions, emphasizing patient education, collaboration, and evidence-based recommendations for effective use.